Colorectal Cancer Clinical Trial
Official title:
A Randomized Prospective Trial Comparing Split Dose Polyethylene Glycol-Based Lavage With Clear Fluids Versus Split Dose Polyethylene Glycol-Based Lavage With a Low-Residue Diet in Preparation of Patients for Colonoscopy.
The objective of the study is to examine the effect of adding a strict low-residue lunch on
the day before colonoscopy has on clinical efficacy and patient tolerability of bowel
preparation, with patients receiving split-dose Polyethylene Glycol Based Lavage.
The primary outcomes will be 1) quality of preparation in cleansing the colon and 2) patient
satisfaction
All patients between the ages 18-74 years referred to the Forzani MacPhail Colon Cancer
Screening Centre (CCSC) in Calgary, Alberta, Canada for colonoscopy will be considered for
inclusion. During pre-assessments at the clinic, patients are asked to consider a general
research consent. If they agree to that, then they will be approached for consideration of
participating in this study and presented with an "Invitation to Participate in a Research
Study" form ; the study assistant will obtain final consent if they agree. Those not
interested in participating will simply receive their physician's standard bowel preparation
protocol. There will be no coercion of any sort. Enrollment of participants will be
performed with block randomizations of 2, 4, 6 and 8 by using a computer-generated table,
with allocation concealment maintained through the use of consecutively numbered sealed
envelopes. Colonoscopists and investigators will be blinded to allocation groups. Patients
will be allocated to one of two groups: (1) Split dose Polyethylene Glycol Based Lavage (2L
+ 2L) with Standard dietary instructions- a low fibre diet for 4 days prior to colonoscopy
and clear fluids after a low-fibre breakfast on the day before procedure; (2) Split dose
Polyethylene Glycol Based Lavage (2L + 2L) with Low Fibre Lunch dietary instructions- a low
fibre diet for 4 days prior to colonoscopy and clear fluids after a low-fibre breakfast and
low-fibre lunch on the day before procedure
A study assistant will assign patients to their group based on the Randomization and
instruct them on the proper use of their assigned bowel preparation method. Patients will be
given a tolerability questionnaire, which has been modified from a previously used
questionnaire, to be completed once their bowel preparation is finished and before coming to
the CCSC for the colonoscopy (included in the appendix). Patient concerns or questions
regarding the preparation will be directed toward the study assistant or clinic nurses as
opposed to their endoscopist, so as to avoid un-blinding the Colonoscopist. The physician
performing the procedure will then complete an Ottawa Bowel Preparation Scale, a validated
Simplified Bowel Preparation scale and a New Bowel Prep Scale to assess colon cleanliness.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor)
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
| Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
| Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
| Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
| Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
| Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
| Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
| Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
| Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
| Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
| Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
| Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
| Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
| Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |